欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SK/H/0261/001
药品名称Sitagliptin Glenmark 25 mg/ml oral solution
活性成分
    • Sitagliptin Hydrochloride monohydrate 25.0 mg/ml
剂型Oral solution
上市许可持有人Glenmark Pharmaceuticals s.r.o. Hvezdova 1716/2B Prague 4, 14078 Czechia
参考成员国 - 产品名称Slovakia (SK)
互认成员国 - 产品名称
    • Czechia (CZ)
      Sitagliptin Glenmark 50 mg/2 ml perorální roztok
    • Spain (ES)
许可日期2021/12/08
最近更新日期2024/11/15
药物ATC编码
    • A10BH01 sitagliptin
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase